Clinical Trials Directory

Trials / Unknown

UnknownNCT01311804

An Efficacy and Safety Study of Periarticular Parecoxib Sodium for Pain Management in Total Knee Arthroplasty

An Open Label,Multicentre, Randomized Trial to Determine the Efficacy of Periarticular Parecoxib Sodium In A Multimodal Cocktail vs Intravenous Parecoxib Sodium for Pain Management in Total Knee Arthroplasty

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
125 (estimated)
Sponsor
Ministry of Health, Malaysia · Other Government
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Primary Research Objective: The primary objective of this study is to determine efficacy of periarticular parecoxib sodium in a multimodal cocktail versus intravenous parecoxib injections for pain management in total knee arthroplasty Secondary Research Objective: * To determine if perioperative use of parecoxib sodium was associated with improved clinical outcomes * To evaluate the safety, in terms of adverse events; serious adverse events and tolerability of parecoxib sodium in periarticular injections in a multimodal cocktail

Detailed description

This is a multi-center, open label, parallel randomized trial designed to evaluate the efficacy and safety of periarticular parecoxib sodium compared to intravenous parecoxib sodium. 125 patients with primary knee osteoarthritis from 4 participating sites who meet inclusion/exclusion criteria will be enrolled into the trial. After initial screening, patients will attend clinic for baseline examination. Subjects will then randomly allocated to periarticular parecoxib sodium or intravenous sodium in ratio of 1:1. patients are observed at post-operative 6, 12, 24 hours, subsequently daily for 4 days and finally at 2 week follow-up

Conditions

Interventions

TypeNameDescription
PROCEDUREparecoxib sodiumperiarticular parecoxib sodium injection will be given during total knee arthroplasty
PROCEDUREparecoxib sodiumintravenous parecoxib sodium during total knee arthroplasty

Timeline

Start date
2011-04-01
Primary completion
2011-04-01
Completion
2011-10-01
First posted
2011-03-10
Last updated
2011-03-10

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT01311804. Inclusion in this directory is not an endorsement.